Loading...

Exprivia

BIT:XPR
Snowflake Description

Moderate growth potential and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
XPR
BIT
€57M
Market Cap
  1. Home
  2. IT
  3. Software
Company description

Exprivia S.p.A. provides digital transformation solutions in Italy and internationally. The last earnings update was 37 days ago. More info.


Add to Portfolio Compare Print
XPR Share Price and Events
7 Day Returns
1.2%
BIT:XPR
-0.6%
IT Software
0%
IT Market
1 Year Returns
-13.2%
BIT:XPR
-7.2%
IT Software
-7.9%
IT Market
XPR Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Exprivia (XPR) 1.2% -7.7% 22.9% -13.2% 53.6% 31.8%
IT Software -0.6% -0.1% 10% -7.2% 46.5% 35.7%
IT Market 0% 1.7% 8.9% -7.9% -9.2% -34.3%
1 Year Return vs Industry and Market
  • XPR underperformed the Software industry which returned -7.2% over the past year.
  • XPR underperformed the Market in Italy which returned -7.9% over the past year.
Price Volatility
XPR
Industry
5yr Volatility vs Market

XPR Value

 Is Exprivia undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Exprivia to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Exprivia.

BIT:XPR Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 1 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 21%
Perpetual Growth Rate 10-Year IT Government Bond Rate 2.9%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for BIT:XPR
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year IT Govt Bond Rate 2.9%
Equity Risk Premium S&P Global 9%
Software Unlevered Beta Simply Wall St/ S&P Global 1.13
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.134 (1 + (1- 24%) (428.16%))
3.561
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
2
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.93% + (2 * 9.02%)
20.97%

Discounted Cash Flow Calculation for BIT:XPR using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Exprivia is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

BIT:XPR DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (EUR, Millions) Source Present Value
Discounted (@ 20.97%)
2019 8.34 Est @ 5.92% 6.90
2020 8.76 Est @ 5.03% 5.99
2021 9.15 Est @ 4.4% 5.17
2022 9.51 Est @ 3.96% 4.44
2023 9.86 Est @ 3.65% 3.80
2024 10.20 Est @ 3.44% 3.25
2025 10.53 Est @ 3.29% 2.78
2026 10.87 Est @ 3.18% 2.37
2027 11.20 Est @ 3.11% 2.02
2028 11.55 Est @ 3.05% 1.72
Present value of next 10 years cash flows €38.44
BIT:XPR DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= €11.55 × (1 + 2.93%) ÷ (20.97% – 2.93%)
€65.89
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= €65.89 ÷ (1 + 20.97%)10
€9.81
BIT:XPR Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= €38.44 + €9.81
€48.25
Equity Value per Share
(EUR)
= Total value / Shares Outstanding
= €48.25 / 48.24
€1
BIT:XPR Discount to Share Price
Calculation Result
Value per share (EUR) From above. €1.00
Current discount Discount to share price of €1.18
= -1 x (€1.18 - €1.00) / €1.00
-18%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Exprivia is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Exprivia's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Exprivia's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BIT:XPR PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in EUR €-0.02
BIT:XPR Share Price ** BIT (2019-04-18) in EUR €1.18
Italy Software Industry PE Ratio Median Figure of 6 Publicly-Listed Software Companies 26.25x
Italy Market PE Ratio Median Figure of 241 Publicly-Listed Companies 15.82x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Exprivia.

BIT:XPR PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= BIT:XPR Share Price ÷ EPS (both in EUR)

= 1.18 ÷ -0.02

-69.95x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Exprivia is loss making, we can't compare its value to the IT Software industry average.
  • Exprivia is loss making, we can't compare the value of its earnings to the Italy market.
Price based on expected Growth
Does Exprivia's expected growth come at a high price?
Raw Data
BIT:XPR PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -69.95x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
Not available
Europe Software Industry PEG Ratio Median Figure of 75 Publicly-Listed Software Companies 2.12x
Italy Market PEG Ratio Median Figure of 160 Publicly-Listed Companies 1.28x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Exprivia, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Exprivia's assets?
Raw Data
BIT:XPR PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in EUR €1.49
BIT:XPR Share Price * BIT (2019-04-18) in EUR €1.18
Italy Software Industry PB Ratio Median Figure of 9 Publicly-Listed Software Companies 2.9x
Italy Market PB Ratio Median Figure of 315 Publicly-Listed Companies 1.54x
BIT:XPR PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= BIT:XPR Share Price ÷ Book Value per Share (both in EUR)

= 1.18 ÷ 1.49

0.79x

* Primary Listing of Exprivia.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Exprivia is good value based on assets compared to the IT Software industry average.
X
Value checks
We assess Exprivia's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Software industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Software industry average (and greater than 0)? (1 check)
  5. Exprivia has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

XPR Future Performance

 How is Exprivia expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
92.9%
Expected annual growth in earnings per share.
Earnings growth vs Low Risk Savings
Is Exprivia expected to grow at an attractive rate?
  • Exprivia's earnings growth is expected to exceed the low risk savings rate of 2.9%.
Growth vs Market Checks
  • Exprivia's earnings growth is expected to exceed the Italy market average.
  • Exprivia's revenue growth is positive but not above the Italy market average.
Annual Growth Rates Comparison
Raw Data
BIT:XPR Future Growth Rates Data Sources
Data Point Source Value (per year)
BIT:XPR Future Earnings per Share Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 92.9%
BIT:XPR Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 1.8%
Italy Software Industry Earnings Growth Rate Market Cap Weighted Average 42.4%
Italy Software Industry Revenue Growth Rate Market Cap Weighted Average 12.2%
Italy Market Earnings Growth Rate Market Cap Weighted Average 10.5%
Italy Market Revenue Growth Rate Market Cap Weighted Average 3.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BIT:XPR Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BIT:XPR Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31 646 1
2019-12-31 625 1
BIT:XPR Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2018-12-31 623 31 -1
2018-09-30 473 5 -5
2018-06-30 367 22 -7
2018-03-31 235 4 -12
2017-12-31 160 9 0
2017-09-30 153 12 -1
2017-06-30 148 10 2
2017-03-31 144 8 4
2016-12-31 140 12 3
2016-09-30 139 2 5
2016-06-30 137 3 4
2016-03-31 139 -3 4

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Exprivia's earnings are expected to grow significantly at over 20% yearly.
  • Exprivia's revenue is expected to grow by 1.8% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BIT:XPR Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Exprivia Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BIT:XPR Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31 0.18 0.18 0.18 1.00
2019-12-31 0.12 0.12 0.12 1.00
BIT:XPR Past Financials Data
Date (Data in EUR Millions) EPS *
2018-12-31 -0.02
2018-09-30 -0.10
2018-06-30 -0.15
2018-03-31 -0.25
2017-12-31 0.00
2017-09-30 -0.01
2017-06-30 0.04
2017-03-31 0.08
2016-12-31 0.06
2016-09-30 0.09
2016-06-30 0.07
2016-03-31 0.09

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Exprivia is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Exprivia's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Italy market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Italy market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Exprivia has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

XPR Past Performance

  How has Exprivia performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Exprivia's growth in the last year to its industry (Software).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Exprivia does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Exprivia's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Exprivia's 1-year growth to the IT Software industry average as it is not currently profitable.
Earnings and Revenue History
Exprivia's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Exprivia Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BIT:XPR Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 623.21 -0.82 7.49
2018-09-30 472.55 -4.79 3.60
2018-06-30 366.69 -7.11 5.20
2018-03-31 235.21 -11.87 4.31
2017-12-31 159.82 -0.03 3.60
2017-09-30 152.72 -0.63 3.94
2017-06-30 148.24 2.10 3.81
2017-03-31 144.06 4.00 3.85
2016-12-31 139.60 2.82 3.94
2016-09-30 138.54 4.72 4.11
2016-06-30 136.66 3.78 7.26
2016-03-31 139.27 4.41 4.19
2015-12-31 141.08 4.52 4.11
2015-09-30 146.30 3.76 4.62
2015-06-30 148.16 4.42 1.14
2015-03-31 146.69 3.72 4.41
2014-12-31 143.63 3.50 4.62
2014-09-30 137.36 2.99 5.16
2014-06-30 134.96 2.53 5.22
2014-03-31 130.23 1.98 5.33
2013-12-31 128.18 2.42 5.41
2013-09-30 131.43 3.44 5.55
2013-06-30 129.79 3.01 5.29
2013-03-31 136.29 3.65 5.27
2012-12-31 139.35 2.15 5.78
2012-09-30 135.29 2.35 4.09
2012-06-30 131.22 1.60 5.14

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Exprivia has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • Exprivia used its assets less efficiently than the IT Software industry average last year based on Return on Assets.
  • It is difficult to establish if Exprivia improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Exprivia's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Software industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Exprivia has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

XPR Health

 How is Exprivia's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Exprivia's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Exprivia's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Exprivia's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Exprivia's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 1.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Exprivia Company Filings, last reported 3 months ago.

BIT:XPR Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 98.77 243.71 23.67
2018-09-30 82.81 258.59 15.27
2018-06-30 86.54 250.97 33.02
2018-03-31 86.79 263.52 19.54
2017-12-31 101.52 267.54 37.84
2017-09-30 74.28 53.05 11.09
2017-06-30 75.55 52.73 14.35
2017-03-31 76.62 52.47 6.22
2016-12-31 75.74 56.19 12.96
2016-09-30 74.75 54.95 9.40
2016-06-30 73.43 52.69 15.49
2016-03-31 73.81 47.40 7.22
2015-12-31 74.20 46.31 7.55
2015-09-30 71.60 41.20 7.76
2015-06-30 71.67 42.40 10.43
2015-03-31 71.80 39.65 9.56
2014-12-31 72.73 43.42 12.46
2014-09-30 72.52 43.03 5.83
2014-06-30 70.52 44.20 7.26
2014-03-31 70.72 40.90 8.78
2013-12-31 71.19 44.72 7.25
2013-09-30 69.57 43.34 5.24
2013-06-30 68.92 45.32 6.01
2013-03-31 69.29 50.16 8.02
2012-12-31 68.68 49.51 5.34
2012-09-30 66.06 51.56 4.68
2012-06-30 65.83 52.33 10.34
  • Exprivia's level of debt (246.7%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (62.8% vs 246.7% today).
  • Debt is not well covered by operating cash flow (12.8%, less than 20% of total debt).
  • Exprivia is making a loss, therefore interest payments are not well covered by earnings.
X
Financial health checks
We assess Exprivia's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Exprivia has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

XPR Dividends

 What is Exprivia's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Exprivia dividends.
If you bought €2,000 of Exprivia shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Exprivia's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Exprivia's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BIT:XPR Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
Europe Software Industry Average Dividend Yield Market Cap Weighted Average of 80 Stocks 1.5%
Italy Market Average Dividend Yield Market Cap Weighted Average of 182 Stocks 4%
Italy Minimum Threshold Dividend Yield 10th Percentile 1.2%
Italy Bottom 25% Dividend Yield 25th Percentile 2.1%
Italy Top 25% Dividend Yield 75th Percentile 4.4%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BIT:XPR Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2020-12-31
2019-12-31
BIT:XPR Past Annualized Dividends Data
Date (Data in €) Dividend per share (annual) Avg. Yield (%)
2017-11-15 0.000 0.000
2017-11-13 0.000 0.000
2017-08-09 0.000 0.000
2017-08-04 0.000 0.000
2017-05-16 0.000 0.000
2017-05-12 0.000 0.000
2017-03-31 0.000 0.000
2017-03-16 0.000 0.000
2016-03-30 0.021 3.091
2016-03-11 0.021 2.783
2015-03-16 0.028 3.584
2012-08-03 0.031 4.477
2012-03-29 0.031 5.584
2012-03-13 0.031 4.316
2011-03-18 0.040 5.111
2011-03-02 0.040 3.973
2010-04-21 0.040 4.215
2009-04-21 0.040 3.428

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Exprivia has not reported any payouts.
  • Unable to verify if Exprivia's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Exprivia's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Exprivia has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Exprivia's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Exprivia afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Exprivia has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

XPR Management

 What is the CEO of Exprivia's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Domenico Favuzzi
COMPENSATION €370,000
AGE 56
TENURE AS CEO 12.6 years
CEO Bio

Mr. Domenico Favuzzi is the Chairman of the Board at Italtel S.P.A and Italtel Group S.p.A. Mr. Favuzzi has been the Chairman of the Board of Exprivia SpA since March 2008 and has been its Chief Executive Officer since September 2006. Mr. Favuzzi served as President and Managing Director of Exprivia SpA. Mr. Favuzzi served as Chief Executive Officer of Exprivia SpA since September 18, 2005. Mr. Favuzzi serves as Director of Advanced Computer System SpA. He has been an Executive Director of Exprivia SpA since June 29, 2005. He serves as Director of Exprivia Healthcare IT s.r.l. He holds a Degree in Information Science at the University of Beri.

CEO Compensation
  • Domenico's compensation has increased whilst company is loss making.
  • Domenico's remuneration is higher than average for companies of similar size in Italy.
Management Team Tenure

Average tenure and age of the Exprivia management team in years:

0.3
Average Tenure
55.5
Average Age
  • The average tenure for the Exprivia management team is less than 2 years, this suggests a new team.
Management Team

Domenico Favuzzi

TITLE
Chairman & CEO
COMPENSATION
€370K
AGE
56
TENURE
12.6 yrs

Dante Altomare

TITLE
Vice-Chairman
COMPENSATION
€154K
AGE
64

Rosa Daloiso

TITLE
Head of Corporate Services
COMPENSATION
€66K
AGE
52
TENURE
0.3 yrs

Roberto Felline

TITLE
Chief Financial Officer
AGE
55
TENURE
0.3 yrs

Stefano Pileri

TITLE
COO & Director
TENURE
0.3 yrs

Luca Ferraris

TITLE
Head of Innovation
TENURE
0.3 yrs

Giovanni Sebastiano

TITLE
Head of Strategy
TENURE
0.3 yrs

Maurizio Sacchi

TITLE
Head of Human Resources
AGE
57
TENURE
0.3 yrs

Filippo Giannelli

TITLE
Head of MIU Banking
AGE
47
TENURE
0.3 yrs

Vito Farinola

TITLE
Head of DF Business Process Outsourcing
TENURE
0.3 yrs
Board of Directors Tenure

Average tenure and age of the Exprivia board of directors in years:

6.2
Average Tenure
56
Average Age
  • The tenure for the Exprivia board of directors is about average.
Board of Directors

Domenico Favuzzi

TITLE
Chairman & CEO
COMPENSATION
€370K
AGE
56
TENURE
11.1 yrs

Dante Altomare

TITLE
Vice-Chairman
COMPENSATION
€154K
AGE
64

Stefano Pileri

TITLE
COO & Director
TENURE
0.1 yrs

Alessandro Laterza

TITLE
Lead Independent Director
COMPENSATION
€34K
AGE
60
TENURE
7.4 yrs

Ignazio Pellecchia

TITLE
Chairman of Board for Statutory Auditors
COMPENSATION
€53K
AGE
50

Valeria Savelli

TITLE
Non-Executive Director
COMPENSATION
€97K
AGE
56
TENURE
8 yrs

Angela Bergantino

TITLE
Independent Non-Executive Director
COMPENSATION
€9K
AGE
48
TENURE
5 yrs

Gianfranco Viesti

TITLE
Independent Non-Executive Director
COMPENSATION
€14K
AGE
60
TENURE
5 yrs

Eugenio Sciascio

TITLE
Independent Director

Marina Lalli

TITLE
Independent Director
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Exprivia's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Exprivia has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

XPR News

Simply Wall St News

A Look At The Fair Value Of Exprivia S.p.A. (BIT:XPR)

In this article we are going to estimate the intrinsic value of Exprivia S.p.A. … Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model. … We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows

Simply Wall St -

Exprivia Shareholders Have Enjoyed A 66% Share Price Gain

When a company doesn't yet make profits, we'd generally expect to see good revenue growth. … Over the last three years Exprivia has grown its revenue at 41% annually. … While the compound gain of 18% per year over three years is pretty good, you might argue it doesn't fully reflect the strong revenue growth.

Simply Wall St -

How Exprivia S.p.A. (BIT:XPR) Can Impact Your Portfolio Volatility

In finance, Beta is a measure of volatility. … Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). … A stock with a beta greater than one is more sensitive to broader market movements than a stock with a beta of less than one.

Simply Wall St -

Does Exprivia SpA's (BIT:XPR) CEO Salary Reflect Performance?

How Does Domenico Favuzzi's Compensation Compare With Similar Sized Companies. … According to our data, Exprivia SpA has a market capitalization of €43m, and pays its CEO total annual compensation worth €370k. … We looked at a group of companies with market capitalizations under €176m, and the median CEO compensation was €289k.

Simply Wall St -

Exprivia SpA (BIT:XPR): Time For A Financial Health Check

Exprivia SpA (BIT:XPR) is a small-cap stock with a market capitalization of €60.08m. … While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. … Companies operating in the Software industry,

Simply Wall St -

Why You Need To Look At This Factor Before Buying Exprivia Sp.A. (BIT:XPR)

A popular measure of market risk for a stock is its beta, and the market as a whole represents a beta value of one. … As a result, the company may be less volatile relative to broad market movements, compared to a company of similar size but higher proportion of fixed assets. … However, this is the opposite to what XPR’s actual beta value suggests, which is higher stock volatility relative to the market.

Simply Wall St -

Breaking Down Exprivia Sp.A.'s (BIT:XPR) Ownership Structure

In this analysis, my focus will be on developing a perspective on Exprivia Sp.A.’s (BIT:XPR) latest ownership structure, a less discussed, but important factor. … View our latest analysis for Exprivia BIT:XPR Ownership_summary May 7th 18 Institutional Ownership Institutional investors typically buy and sell shares in large magnitudes which can significantly sway the share price, especially when there are relatively small amounts of shares available on the market to trade. … Insider Ownership Another important group of shareholders are company insiders.

Simply Wall St -

Is Exprivia Sp.A.'s (BIT:XPR) Balance Sheet A Threat To Its Future?

XPR's debt levels surged from €54.59M to €260.63M over the last 12 months – this includes both the current and long-term debt. … On top of this, XPR has generated cash from operations of €18.96M over the same time period, leading to an operating cash to total debt ratio of 7.27%, signalling that XPR’s operating cash is not sufficient to cover its debt. … Running high debt, while not yet making money, can be risky in unexpected downturns as liquidity may dry up, making it hard to operate.Next Steps: XPR’s high debt levels is not met with high cash flow coverage.

Simply Wall St -

At €1.358, Is Exprivia Sp.A. (BIT:XPR) A Buy?

(BIT:XPR), a software company based in Italy, saw significant share price volatility over the past couple of months on the BIT, rising to the highs of €1.69 and falling to the lows of €1.36. … This is based on its high beta, which is a good indicator for share price volatility. … Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations.

Simply Wall St -

Exprivia Sp.A.'s (BIT:XPR) Earnings Dropped -113.33%, How Did It Fare Against The Industry?

After looking at Exprivia Sp.A.'s (BIT:XPR) latest earnings announcement (30 September 2017), I found it useful to revisit the company's performance in the past couple of years and assess this against the most recent figures. … View our latest analysis for Exprivia Was XPR's recent earnings decline worse than the long-term trend and the industry? … I look at the ‘latest twelve-month’ data, which annualizes the latest 6-month earnings release, or some times, the latest annual report is already the most recent financial data.

Simply Wall St -

XPR Company Info

Description

Exprivia S.p.A. provides digital transformation solutions in Italy and internationally. The company offers big data and analytics, cloud, Internet of things, IT security, mobile, SAP, and business process outsourcing solutions. It also designs and manages services and infrastructure for call centers, contact centers, and helpdesks; and develops ground stations for the reception and processing of satellite data. In addition, the company organizes and manages Master in Management and Industrial Development program, as well as specialized seminars and training courses for companies and public administration; offers professional and project development services in the SAP environment, IT infrastructure, and WEB portal development; and provides healthcare solutions and information systems. It serves the banking, finance, and insurance; telecom and media; energy and utilities; aerospace and defense; manufacturing and distribution; healthcare; and public sector industries. The company is headquartered in Molfetta, Italy.

Details
Name: Exprivia S.p.A.
XPR
Exchange: BIT
Founded:
€56,918,913
48,236,367
Website: http://www.exprivia.it
Address: Exprivia S.p.A.
Via Adriano Olivetti 11,
Molfetta,
Bari, 70056,
Italy
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
BIT XPR Common Stock Borsa Italiana IT EUR 05. Jun 2000
DB IW7 Common Stock Deutsche Boerse AG DE EUR 05. Jun 2000
BST IW7 Common Stock Boerse-Stuttgart DE EUR 05. Jun 2000
LSE 0NN1 Common Stock London Stock Exchange GB EUR 05. Jun 2000
Number of employees
Current staff
Staff numbers
3,638
Exprivia employees.
Industry
Application Software
Software
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/20 20:36
End of day share price update: 2019/04/18 00:00
Last estimates confirmation: 2019/04/17
Last earnings filing: 2019/03/14
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.